サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788286

医薬品溶出試験サービスの世界市場

Pharmaceutical Dissolution Testing Services

出版日
ページ情報
英文 166 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
医薬品溶出試験サービスの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 166 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品溶出試験サービスの世界市場は2030年までに12億米ドルに達する見込み

2024年に8億70万米ドルと推定される医薬品溶出試験サービスの世界市場は、2024年から2030年にかけてCAGR 6.5%で成長し、2030年には12億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるIn-Vitroは、CAGR 5.5%を記録し、分析期間終了時には7億8,690万米ドルに達すると予測されています。生体内セグメントの成長率は、分析期間中CAGR 8.8%と推定されます。

米国市場は推定2億1,050万米ドル、中国はCAGR6.4％で成長予測

米国の医薬品溶出試験サービス市場は、2024年に2億1,050万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年にかけてCAGR 6.4%で推移し、2030年には1億8,860万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.9%と5.6%と予測されています。欧州では、ドイツがCAGR 5.4%で成長すると予測されています。

世界の医薬品溶出試験サービス市場- 主要動向と促進要因まとめ

医薬品の溶出試験とは何か、なぜ重要なのか？

医薬品の溶出試験は、錠剤、カプセル剤、その他の剤形中の医薬品有効成分（API）が溶液中に放出される速度と程度を評価するために製薬業界で使用される主要な分析手法です。薬剤の生物学的利用能（バイオアベイラビリティ）と有効性を評価するために不可欠な試験であり、摂取された薬剤が体内で効果的に吸収されることを保証します。溶出試験は、消化器系で薬剤がどのように分解されるかを判定するのに役立ち、その薬剤の治療性能に関する洞察を提供します。米国FDAや欧州医薬品庁（EMA）などの規制機関は、医薬品が生体内で意図したとおりに作用することを確認するため、医薬品承認プロセスの一環として溶出試験を義務付けています。

この試験は、新薬の開発、バッチ間の一貫性の判定、規制基準への準拠を確実にするための貴重なデータを提供するため、製薬企業にとって極めて重要です。溶出試験はまた、医薬品の開発および製造プロセス全体の品質管理においても重要な役割を果たしています。医薬品がどのように成分を放出するかを評価することで、メーカーは医薬品の製剤を最適化し、臨床の場で医薬品が期待通りに機能することを確認し、患者の転帰を改善することができます。この試験はまた、溶出プロファイルが標準品と類似していることを確認することにより、ジェネリック医薬品の開発をサポートします。

なぜ医薬品溶出試験サービス市場は拡大しているのか？

医薬品溶出試験サービス市場は、医薬品の品質と有効性に対する需要の高まり、製薬メーカーに対する規制圧力の高まり、ジェネリック医薬品市場の成長など、いくつかの重要な要因により拡大しています。主な要因の1つは、高品質な医薬品に対する需要の高まりです。製薬業界が患者の転帰の改善を重視し続ける中、医薬品が効果的に吸収され、望ましい治療効果を確実にもたらすことは、これまで以上に重要になっています。溶出試験は医薬品開発の基本的な部分であり、製薬会社は自社製品がバイオアベイラビリティに必要な基準を満たしていることを確認できるため、こうしたサービスの需要が高まっています。

規制当局からの圧力も市場成長に寄与する重要な要因です。世界中の規制機関は、医薬品製造管理及び品質管理に関する基準（GMP）やその他の規制を遵守するため、製薬会社に溶出試験の実施を義務付けています。これらの規制は、医薬品の一貫性、安全性、有効性を保証するものです。世界の製薬業界が製品の安全性に関する監視の強化に直面する中、メーカーは規制機関の定める厳しい基準を満たすために溶出試験への投資を増やしています。このようなコンプライアンスに対する要求の高まりは、溶出試験サービスの拡大に拍車をかけており、溶出試験サービスは規制当局の承認を取得し、維持するために不可欠です。

ジェネリック医薬品市場の成長も、医薬品溶出試験サービス市場の拡大に大きな役割を果たしています。ジェネリック医薬品は、その低コストと先発品に匹敵する有効性により市場シェアを拡大しており、溶出試験は、ジェネリック製剤が先発品と生物学的に同等であることを確認するための重要なツールとなっています。ジェネリック医薬品メーカーは、自社の医薬品が先発医薬品と同じ溶出プロファイルを満たしていることを証明しなければならないため、溶出試験サービスのニーズが高まっています。世界のヘルスケアシステムにおけるジェネリック医薬品の普及に伴い、溶出試験サービスの需要は増加すると予想されます。

医薬品溶出試験サービスの将来を形作る主要動向とは？

医薬品溶出試験サービス市場の将来を形成している主な動向には、自動化された試験技術の利用拡大、in vitro-in vivo相関（IVIVC）の台頭、迅速でハイスループットな試験に対する需要の増加などがあります。重要な動向の一つは、自動溶出試験技術の採用が拡大していることです。自動化は、人為的ミスを減らし、より正確な測定を提供することで、試験の効率と一貫性を向上させます。自動化システムは、最小限の手動介入で溶出試験を実施できるため、スループットが向上し、リアルタイムのデータ解析が可能になります。このような技術的進歩により、製薬会社はより大規模で高品質の溶出試験を容易に実施できるようになり、こうしたサービスへの需要が高まっています。

in vitro-in vivo相関（IVIVC）の台頭も、溶出試験サービスの将来に影響を与える重要な動向です。IVIVCは、溶出試験データを用いて、ヒト体内でのバイオアベイラビリティや吸収速度など、薬剤の生体内挙動を予測する技術です。製薬業界がより効率的で費用対効果の高い医薬品開発プロセスへの移行を進める中、IVIVCの活用により臨床試験や薬事承認プロセスを効率化することができます。試験管内での溶出データを生体内での性能と関連付けることで、製薬企業は大規模な臨床試験の必要性を減らし、医薬品開発の迅速化とコスト削減を実現することができます。IVIVCに対する関心の高まりは、こうした高度なモデリング技術をサポートする高度な溶出試験サービスに対する需要を後押ししています。

迅速でハイスループットな試験に対する需要の高まりも、市場の将来を形作る重要な動向です。製薬会社が医薬品開発プロセスのスピードアップに取り組む中、より迅速で効率的な溶出試験のニーズが高まっています。ハイスループット溶出試験では、複数の製剤を同時に試験することができるため、メーカーは短時間で幅広い製剤を評価することができます。このような試験の迅速化への動向は、最小限の遅延で高品質の結果を提供できる、より高度で自動化された溶出試験技術の開発を後押しし、医薬品溶出試験サービス市場の成長をさらに促進しています。

医薬品溶出試験サービス市場の成長促進要因は？

医薬品溶出試験サービス市場の成長は、医薬品開発の効率化、技術の進歩、規制遵守の必要性など、いくつかの要因によってもたらされます。主な要因の1つは、医薬品開発の効率化に対する需要の高まりです。製薬会社が新薬の市場投入までの時間を短縮することを目指しているため、より迅速で正確な溶出試験の必要性が高まっています。自動化とハイスループット試験により、製薬会社は試験プロセスを加速し、開発サイクルをより迅速に進めることができ、市場開拓に貢献しています。

溶出試験装置と技術の技術的進歩も市場の成長を後押ししています。自動化、リアルタイムモニタリング、データ解析を組み込んだより高度な溶出試験システムの開発により、試験の精度とスピードが向上しています。こうした技術革新により、溶出試験はより利用しやすく、効率的で費用対効果の高いものとなっており、製薬企業全体でこうしたサービスの採用が増加しています。また、データ分析や試験管理のための統合ソフトウェアプラットフォームなどの先進技術により、溶出データの管理や解釈が容易になり、こうしたサービスの需要が高まっています。

規制コンプライアンスへの注目が高まっていることも、医薬品溶出試験サービス市場の成長に寄与する重要な要因です。規制機関は製薬企業に対し、安全性、有効性、品質を確保するために、医薬品が特定の溶出基準を満たすことを証明するよう求めています。世界の規制基準の高まりに伴い、製薬企業はFDAやEMAなどの機関が定める要件を満たすために溶出試験サービスに投資する必要があります。これらの規制を遵守することは、市場認可を取得・維持する上で極めて重要であり、製薬業界がより厳しい規制当局の監視に直面する中、溶出試験サービスに対する需要は今後も伸び続けるであろう。

最後に、ジェネリック医薬品市場の拡大が溶出試験サービスの必要性を高めています。ジェネリック医薬品は、規制当局の承認を得るために、先発医薬品と同じ溶出プロファイルを有することを証明しなければなりません。ジェネリック医薬品の需要が増加し続ける中、ジェネリック医薬品と基準製品の生物学的同等性を保証する溶出試験サービスのニーズも高まっています。この動向は、世界のジェネリック医薬品の入手可能性の増加と相まって、溶出試験サービス市場の成長に大きく寄与すると予想されます。

セグメント

手法（in-vitro、in-vivo）;剤形（カプセル、錠剤、その他）;溶解装置（バスケット、パドル、その他）

調査対象企業の例

  • Agilent Technologies, Inc.
  • Almac Group
  • BA Sciences
  • Catalent Pharma Solutions
  • Charles River Laboratories
  • Copley Scientific
  • CoreRx, Inc
  • Dalton Pharma Services
  • Distek, Inc.
  • EAG Laboratories
  • Eurofins Scientific
  • Intertek Group plc
  • Lubrizol Life Science Health
  • Pace Analytical Life Sciences
  • Reading Scientific Services Ltd（RSSL）
  • SOTAX Pharma Services
  • Sterling Pharmaceutical Services
  • Synergy Bioscience
  • Teledyne Hanson Research
  • Vici Health Sciences

AI統合

私たちは、検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32556

Global Pharmaceutical Dissolution Testing Services Market to Reach US$1.2 Billion by 2030

The global market for Pharmaceutical Dissolution Testing Services estimated at US$800.7 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. In-Vitro, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$786.9 Million by the end of the analysis period. Growth in the In-Vivo segment is estimated at 8.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$210.5 Million While China is Forecast to Grow at 6.4% CAGR

The Pharmaceutical Dissolution Testing Services market in the U.S. is estimated at US$210.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$188.6 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Pharmaceutical Dissolution Testing Services Market - Key Trends & Drivers Summarized

What Is Pharmaceutical Dissolution Testing and Why Is It Critical?

Pharmaceutical dissolution testing is a key analytical method used in the pharmaceutical industry to assess the rate and extent to which the active pharmaceutical ingredient (API) in a tablet, capsule, or other dosage form is released into a solution. It is an essential test used to evaluate the bioavailability and efficacy of drugs, ensuring that the medication will be absorbed effectively by the body once ingested. The dissolution test helps determine how a drug breaks down in the digestive system, providing insight into its therapeutic performance. Regulatory agencies like the U.S. FDA and the European Medicines Agency (EMA) require dissolution testing as part of the drug approval process to ensure that the medication behaves as intended in vivo.

This testing is critical for pharmaceutical companies, as it provides valuable data for developing new medications, determining batch-to-batch consistency, and ensuring compliance with regulatory standards. Dissolution testing also plays a vital role in quality control throughout the drug development and manufacturing processes. By evaluating how drugs release their ingredients, manufacturers can optimize drug formulations and ensure that medications perform as expected in clinical settings, thus improving patient outcomes. This testing also supports the development of generic drugs by confirming that their dissolution profiles are similar to that of the reference product.

Why Is the Pharmaceutical Dissolution Testing Services Market Expanding?

The pharmaceutical dissolution testing services market is expanding due to several key factors, including the rising demand for drug quality and efficacy, increasing regulatory pressure on pharmaceutical manufacturers, and the growth of the generic drug market. One of the primary drivers is the increasing demand for high-quality medications. As the pharmaceutical industry continues to focus on improving patient outcomes, ensuring that drugs are effectively absorbed and deliver the desired therapeutic effect is more important than ever. Dissolution testing is a fundamental part of drug development, allowing pharmaceutical companies to verify that their products meet the necessary standards for bioavailability, which has driven the demand for these services.

Regulatory pressure is another key factor contributing to market growth. Regulatory bodies worldwide require pharmaceutical companies to perform dissolution testing to comply with Good Manufacturing Practices (GMP) and other quality control regulations. These regulations ensure that drugs are consistent, safe, and effective. As the global pharmaceutical industry faces increasing scrutiny over product safety, manufacturers are investing more in dissolution testing to meet the stringent standards set by regulatory agencies. This growing demand for compliance has spurred the expansion of dissolution testing services, which are essential for obtaining and maintaining regulatory approval.

The growth of the generic drug market is also playing a significant role in the expansion of the pharmaceutical dissolution testing services market. As generic drugs gain market share due to their lower cost and comparable efficacy to branded products, dissolution testing has become a critical tool for ensuring that generic formulations are bioequivalent to their branded counterparts. This has increased the need for dissolution testing services, as generic manufacturers must demonstrate that their drugs meet the same dissolution profiles as the original drug. With the increasing prevalence of generics in the global healthcare system, the demand for dissolution testing services is expected to rise.

What Key Trends Are Shaping the Future of Pharmaceutical Dissolution Testing Services?

Several key trends are shaping the future of the pharmaceutical dissolution testing services market, including the growing use of automated testing technologies, the rise of in vitro-in vivo correlation (IVIVC), and the increasing demand for rapid and high-throughput testing. One significant trend is the growing adoption of automated dissolution testing technologies. Automation improves the efficiency and consistency of testing by reducing human error and providing more precise measurements. Automated systems can perform dissolution tests with minimal manual intervention, increasing throughput and allowing for real-time data analysis. This technological advancement is making it easier for pharmaceutical companies to perform high-quality dissolution testing on a larger scale, which is driving the demand for these services.

The rise of in vitro-in vivo correlation (IVIVC) is another key trend influencing the future of dissolution testing services. IVIVC is a technique that uses dissolution testing data to predict the in vivo behavior of a drug, such as its bioavailability and absorption rate in the human body. As the pharmaceutical industry increasingly moves toward more efficient and cost-effective drug development processes, the use of IVIVC can streamline clinical trials and regulatory approval processes. By linking in vitro dissolution data to in vivo performance, pharmaceutical companies can reduce the need for extensive clinical studies, making drug development faster and less costly. This growing interest in IVIVC is driving the demand for advanced dissolution testing services that can support these sophisticated modeling techniques.

The increasing demand for rapid and high-throughput testing is another important trend shaping the future of the market. As pharmaceutical companies work to speed up the drug development process, there is a growing need for faster, more efficient dissolution testing. High-throughput dissolution testing allows for the simultaneous testing of multiple formulations, helping manufacturers evaluate a wide range of formulations in a shorter time. This trend toward faster testing is pushing the development of more advanced and automated dissolution testing technologies that can provide high-quality results with minimal delays, further driving the growth of the pharmaceutical dissolution testing services market.

What Are the Key Drivers of Growth in the Pharmaceutical Dissolution Testing Services Market?

The growth in the pharmaceutical dissolution testing services market is driven by several factors, including increasing demand for drug development efficiency, technological advancements, and the need for regulatory compliance. One of the key drivers is the growing demand for efficiency in drug development. As pharmaceutical companies aim to shorten time-to-market for new drugs, the need for faster and more accurate dissolution testing has risen. Automation and high-throughput testing allow pharmaceutical companies to accelerate the testing process and move more quickly through the development cycle, contributing to market growth.

Technological advancements in dissolution testing equipment and techniques are also driving the market's growth. The development of more advanced dissolution testing systems that incorporate automation, real-time monitoring, and data analytics has improved the accuracy and speed of testing. These innovations are making dissolution testing more accessible, efficient, and cost-effective, which has increased the adoption of these services across pharmaceutical companies. Advanced technologies, such as integrated software platforms for data analysis and testing management, are also making it easier for companies to manage and interpret dissolution data, driving demand for these services.

The increasing focus on regulatory compliance is another key factor contributing to the growth of the pharmaceutical dissolution testing services market. Regulatory agencies require pharmaceutical companies to demonstrate that their drugs meet specific dissolution criteria to ensure safety, efficacy, and quality. With growing global regulatory standards, pharmaceutical companies must invest in dissolution testing services to meet the requirements set by agencies such as the FDA and EMA. Compliance with these regulations is crucial for obtaining and maintaining market approval, and the demand for dissolution testing services will continue to grow as the industry faces stricter regulatory scrutiny.

Lastly, the expansion of the generic drug market is driving the need for dissolution testing services. Generic drugs must demonstrate that they have the same dissolution profile as their branded counterparts to be approved by regulatory authorities. As the demand for generics continues to rise, the need for dissolution testing services to ensure bioequivalence between generic and reference products is also growing. This trend, coupled with the increasing availability of generic drugs worldwide, is expected to significantly contribute to the growth of the dissolution testing services market.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Dissolution Testing Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Method (In-Vitro, In-Vivo); Form (Capsules, Tablets, Others); Dissolution Apparatus (Basket, Paddle, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Agilent Technologies, Inc.
  • Almac Group
  • BA Sciences
  • Catalent Pharma Solutions
  • Charles River Laboratories
  • Copley Scientific
  • CoreRx, Inc
  • Dalton Pharma Services
  • Distek, Inc.
  • EAG Laboratories
  • Eurofins Scientific
  • Intertek Group plc
  • Lubrizol Life Science Health
  • Pace Analytical Life Sciences
  • Reading Scientific Services Ltd (RSSL)
  • SOTAX Pharma Services
  • Sterling Pharmaceutical Services
  • Synergy Bioscience
  • Teledyne Hanson Research
  • Vici Health Sciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pharmaceutical Dissolution Testing Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Regulatory Focus on Bioavailability and Product Consistency Drives Demand for Accurate Dissolution Testing Services
    • Growth in Generic Drug Approvals Fuels Need for Comparative Dissolution Profiling and Bioequivalence Testing
    • Rising Complexity in Modified-Release and Poorly Soluble Formulations Spurs Demand for Customized Testing Protocols
    • Outsourcing Trend Among Small and Mid-Sized Pharma Strengthens Market for Specialized Dissolution Testing Providers
    • Increasing Global Harmonization of Pharmacopeial Standards Supports Demand for Cross-Market Testing Expertise
    • Advancements in Dissolution Apparatus and Automation Enhance Throughput, Reproducibility, and Data Integrity
    • Integration of Biorelevant Dissolution Media into Testing Protocols Aligns With Evolving FDA and EMA Expectations
    • Growth of Orally Disintegrating and Pediatric Dosage Forms Expands Scope of Dissolution Method Development
    • Use of Dissolution Testing in Stability and Shelf-Life Studies Increases Demand for Long-Term Analytical Services
    • Digitalization and LIMS Integration Improve Workflow Efficiency and Compliance Across Testing Labs
    • Increased Importance of IVIVC (In Vitro-In Vivo Correlation) Models Spurs Investment in Predictive Dissolution Services
    • Rising R&D Spend on Complex Generics and 505(b)(2) Pathways Strengthens the Business Case for Outsourced Testing
    • Focus on Continuous Manufacturing and PAT (Process Analytical Technology) Supports Real-Time Dissolution Monitoring
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pharmaceutical Dissolution Testing Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for In-Vitro by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for In-Vitro by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for In-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for In-Vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Basket by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Basket by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Paddle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Paddle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Dissolution Apparatus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Dissolution Apparatus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • JAPAN
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • CHINA
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • EUROPE
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • FRANCE
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • GERMANY
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Dissolution Testing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Form - Capsules, Tablets and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Form - Percentage Breakdown of Value Sales for Capsules, Tablets and Other Forms for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Basket, Paddle and Other Dissolution Apparatus - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Pharmaceutical Dissolution Testing Services by Dissolution Apparatus - Percentage Breakdown of Value Sales for Basket, Paddle and Other Dissolution Apparatus for the Years 2025 & 2030

IV. COMPETITION